- Home
- OPK vs EVMN Comparison
OPK vs EVMN Comparison
Compare OPK & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPK | EVMN |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | United States |
| Employees | N/A | 48 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 921.2M | 825.5M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | OPK | EVMN |
|---|---|---|
| Price | $1.11 | $23.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $1.60 | ★ $43.88 |
| AVG Volume (30 Days) | ★ 2.0M | 282.1K |
| Earning Date | 04-28-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $13.89 |
| 52 Week High | $1.60 | $33.20 |
Technical Indicators
Market Signals| Indicator | OPK | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 36.94 | 43.35 |
| Support Level | $0.98 | $21.39 |
| Resistance Level | $1.25 | $25.50 |
| Average True Range (ATR) | 0.04 | 1.60 |
| MACD | -0.01 | -0.28 |
| Stochastic Oscillator | 45.92 | 23.71 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.